Literature DB >> 25531237

Diverse Francisella tularensis strains and oropharyngeal tularemia, Turkey.

Yasemin Özsürekci, Dawn N Birdsell, Melda Çelik, Eda Karadağ-Öncel, Anders Johansson, Mats Forsman, Amy J Vogler, Paul Keim, Mehmet Ceyhan, David M Wagner.   

Abstract

Entities:  

Mesh:

Year:  2015        PMID: 25531237      PMCID: PMC4285279          DOI: 10.3201/eid2101.141087

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


× No keyword cloud information.
To the Editor: Tularemia is a zoonosis caused by the bacterium Francisella tularensis; the main forms of disease that occur in humans are ulceroglandular/glandular, oculoglandular, oropharyngeal, and respiratory. In Turkey, tularemia outbreaks were described as early as 1936–1938 (), but tularemia was not reportable until 2004. Recently, multiple tularemia outbreaks in Turkey have been described, including in regions where the disease has not been previously reported; it is now considered a reemerging zoonotic disease in Turkey (). The only F. tularensis subspecies found in most of Eurasia, including Turkey, is holarctica. Genetic diversity is low, probably because emergence is recent (). However, discovery of whole-genome single-nucleotide polymorphisms (SNPs), coupled with subsequent canonical SNP (canSNP) analyses, have identified numerous phylogenetic groups within this subspecies. The distinct phylogeographic patterns provide insight into its evolutionary history (–). From December 2009 through January 2011, tularemia outbreaks increased in Turkey, primarily in the central region (). Oropharyngeal tularemia was diagnosed for 14 patients (13 children, 1 adult), and fine-needle lymph node aspiration was performed at the Pediatric Infectious Diseases Unit at Hacettepe University, Ankara. DNA was extracted from these 14 samples (QIAamp DNA Mini Kit; QIAGEN, Hilden, Germany) and screened by using a PCR selective for the tul4 gene region specific to F. tularensis (); all 14 samples were positive for F. tularensis (Table). Residual, de-identified portions of these 14 DNA extracts were used for this study.
Table

Francisella tularensis–positive clinical samples from 14 patients with oropharyngeal tularemia, Turkey, December 2009–January 2011*

Patient no. (sample no.)CityCanSNP subgroup†MLVA genotype‡
1 (F0737)CorumB.20/21/33i
2 (F0738)CankırıB.28/29b
3 (F0739)YozgatB.28/29b
4 (F0740)ZonguldakB.7/8a
5 (F0741)CorumB.20/21/33e
6 (F0742)CorumB.20/21/33e
7 (F0743)CorumB.20/21/33§ND
8 (F0744)¶Bala/AnkaraB.20/21/33e
9 (F0745)AnkaraB.20/21/33d
10 (F0746)CorumB.20/21/33j
11 (F0747)Bala/AnkaraB.20/21/33g
12 (F0748)CorumB.20/21/33f
13 (F0749)AnkaraB.20/21/33c
14 (F0750)Emirdağ/AfyonB.20/21/33h

*Clinical samples collected in 2011 from patients with cervical lymphadenitis at Hacettepe University Medical Faculty, Pediatric Infectious Disease unit, Ankara, Turkey. CanSNP, canonical single-nucleotide polymorphism; MLVA, multilocus variable-number tandem-repeat analysis; ND, not determined.
†Subgroups published in (,,,). CanSNP branches tested on samples in this study: B.3, B.4, B.5, B.6, B.7, B.8, B.9, B.10, B.11, B.13, B.20, B.21, B.22, B.26, B.27, B.28, B.29, B.30, B.31, B.32, and B.33.
‡MLVA markers (M03, M05, M06, M20) ().
§Subgroup classification based on approximation because genotype for B.33 remains unresolved.
¶This patient was an adult (all others were children).

*Clinical samples collected in 2011 from patients with cervical lymphadenitis at Hacettepe University Medical Faculty, Pediatric Infectious Disease unit, Ankara, Turkey. CanSNP, canonical single-nucleotide polymorphism; MLVA, multilocus variable-number tandem-repeat analysis; ND, not determined.
†Subgroups published in (,,,). CanSNP branches tested on samples in this study: B.3, B.4, B.5, B.6, B.7, B.8, B.9, B.10, B.11, B.13, B.20, B.21, B.22, B.26, B.27, B.28, B.29, B.30, B.31, B.32, and B.33.
‡MLVA markers (M03, M05, M06, M20) ().
§Subgroup classification based on approximation because genotype for B.33 remains unresolved.
¶This patient was an adult (all others were children). Genetic characterization led to assignment of these 14 samples to multiple phylogenetic groups within F. tularensis subsp. holarctica. Analysis with 18 previously described (,,,) canSNP assays (Table) led to assignment of the 14 samples to 3 previously described phylogenetic groups within this subspecies: B.20/21/33 (n = 11), B.28/29 (n = 2), and B.7/8 (n = 1) (Table; Technical Appendix). To identify additional genetic diversity, we used 4 previously described () variable-number tandem-repeat markers (M03, M05, M06, and M20) and identified 10 genotypes among the 14 samples, 8 of which were identified in the 11 B.20/21/33 samples (Table). The genetic diversity among these samples and their widespread geographic origins from 6 provinces in central Turkey (Table; Technical Appendix) suggest that the patients contracted tularemia from multiple independent sources. These sources might have been contaminated drinking water, which has been implicated as the source of human tularemia in previous outbreaks in Turkey () and could account for oropharyngeal tularemia in the 14 patients reported here. The finding of these 3 phylogenetic groups within Turkey expands the known geographic range of these phylogenetic groups within F. tularensis subsp. holarctica. The presence of group B.28/29 F. tularensis in Turkey is not surprising; isolates belonging to this group were previously identified in bordering Georgia (). Likewise, the presence of group B.20/21/33 F. tularensis is not unexpected, given the wide geographic distribution (Sweden, Finland, Russia, and Hungary []) of organisms belonging to this group (Technical Appendix). Isolating group B.7/8 F. tularensis, previously thought to occur only in Scandinavia, in Turkey is of particular interest, given the relatively basal position of this group in the F. tularensis subsp. holarctica phylogeny (Technical Appendix). Indeed, descendants of this group have, to date, been identified from North America only, suggesting a transfer from the Old World to the New World within this lineage (). The circumstances of this transfer are unknown but might be discerned through additional knowledge of the geographic extent and genetic diversity of organisms in the B.7/8 group. It has been suggested that Scandinavia might be the source of the historical spread of tularemia to the rest of Europe and might be the origin of the ancestor to the B.13 clade (). This suggestion was previously argued because F. tularensis subsp. holarctica isolates from Sweden have yielded more phylogenetic diversity than isolates from any other country. Indeed, except for the B.27 clade, much of the known phylogenetic diversity of this organism within Europe is present in Sweden (). Some of the largest sets of analyzed samples originated in Sweden (–), whereas eastern Europe and much of Asia remain mostly undersampled. The high genetic diversity identified in our very limited sample set from Turkey is notable and includes 2 major lineages (B.7 and B.13; Technical Appendix). These findings, together with the recent discovery that organisms of multiple F. tularensis subsp. holarctica phylogenetic groups exist in China (), suggest that much additional phylogenetic diversity within this subspecies remains to be discovered in Eurasia, which will provide better information about the evolutionary history and historical spread of F. tularensis subsp. holarctica. We have demonstrated that high-resolution genetic characterization of F. tularensis DNA extracted from biopsy samples is possible, and we conclude that oropharyngeal human tularemia in Turkey is caused by organisms of multiple distinct phylogenetic groups within this subspecies. This pattern, together with the wide geographic distribution of the 14 patients within Turkey (Technical Appendix), suggests that the persons infected by F. tularensis during the 2009–2011 outbreaks in Turkey obtained their infections from multiple environmental sources.

Technical Appendix

Global phylogeography of Francisella tularensis subsp. holarctica and location of 14 clinical samples from Turkey.
  10 in total

1.  An optimized, multiplexed multi-locus variable-number tandem repeat analysis system for genotyping Francisella tularensis.

Authors:  A J Vogler; D Birdsell; D M Wagner; P Keim
Journal:  Lett Appl Microbiol       Date:  2008-11-19       Impact factor: 2.858

2.  The phylogeographic pattern of Francisella tularensis in Sweden indicates a Scandinavian origin of Eurosiberian tularaemia.

Authors:  Edvin Karlsson; Kerstin Svensson; Petter Lindgren; Mona Byström; Andreas Sjödin; Mats Forsman; Anders Johansson
Journal:  Environ Microbiol       Date:  2012-12-16       Impact factor: 5.491

3.  Comparative analysis of PCR versus culture for diagnosis of ulceroglandular tularemia.

Authors:  A Johansson; L Berglund; U Eriksson; I Göransson; R Wollin; M Forsman; A Tärnvik; A Sjöstedt
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

4.  A real-time PCR array for hierarchical identification of Francisella isolates.

Authors:  Kerstin Svensson; Malin Granberg; Linda Karlsson; Vera Neubauerova; Mats Forsman; Anders Johansson
Journal:  PLoS One       Date:  2009-12-21       Impact factor: 3.240

5.  Tularemia in central Anatolia.

Authors:  A Ulu-Kilic; G Gulen; F Sezen; S Kilic; I Sencan
Journal:  Infection       Date:  2012-10-27       Impact factor: 3.553

Review 6.  Re-emergence of tularemia in Turkey.

Authors:  Halis Akalin; Safiye Helvaci; Suna Gedikoğlu
Journal:  Int J Infect Dis       Date:  2008-12-31       Impact factor: 3.623

7.  Phylogeography of Francisella tularensis: global expansion of a highly fit clone.

Authors:  Amy J Vogler; Dawn Birdsell; Lance B Price; Jolene R Bowers; Stephen M Beckstrom-Sternberg; Raymond K Auerbach; James S Beckstrom-Sternberg; Anders Johansson; Ashley Clare; Jordan L Buchhagen; Jeannine M Petersen; Talima Pearson; Josée Vaissaire; Michael P Dempsey; Paul Foxall; David M Engelthaler; David M Wagner; Paul Keim
Journal:  J Bacteriol       Date:  2009-02-27       Impact factor: 3.490

8.  Phylogeography of Francisella tularensis subspecies holarctica from the country of Georgia.

Authors:  Gvantsa Chanturia; Dawn N Birdsell; Merab Kekelidze; Ekaterine Zhgenti; George Babuadze; Nikoloz Tsertsvadze; Shota Tsanava; Paata Imnadze; Stephen M Beckstrom-Sternberg; James S Beckstrom-Sternberg; Mia D Champion; Shripad Sinari; Miklos Gyuranecz; Jason Farlow; Amanda H Pettus; Emily L Kaufman; Joseph D Busch; Talima Pearson; Jeffrey T Foster; Amy J Vogler; David M Wagner; Paul Keim
Journal:  BMC Microbiol       Date:  2011-06-17       Impact factor: 3.605

9.  Phylogeography of Francisella tularensis subsp. holarctica, Europe.

Authors:  Miklós Gyuranecz; Dawn N Birdsell; Wolf Splettstoesser; Erik Seibold; Stephen M Beckstrom-Sternberg; László Makrai; László Fodor; Massimo Fabbi; Nadia Vicari; Anders Johansson; Joseph D Busch; Amy J Vogler; Paul Keim; David M Wagner
Journal:  Emerg Infect Dis       Date:  2012-02       Impact factor: 6.883

10.  Diversity of Francisella tularensis subsp. holarctica lineages, China.

Authors:  Yanhua Wang; Yao Peng; Rong Hai; Lianxu Xia; Hang Li; Zhikai Zhang; Hong Cai; Ying Liang; Xiaona Shen; Dongzheng Yu; Dawn Birdsell; David M Wagner; Paul Keim
Journal:  Emerg Infect Dis       Date:  2014-07       Impact factor: 6.883

  10 in total
  7 in total

1.  Low cost, low tech SNP genotyping tools for resource-limited areas: Plague in Madagascar as a model.

Authors:  Cedar L Mitchell; Voahangy Andrianaivoarimanana; Rebecca E Colman; Joseph Busch; Heidie Hornstra-O'Neill; Paul S Keim; David M Wagner; Minoarisoa Rajerison; Dawn N Birdsell
Journal:  PLoS Negl Trop Dis       Date:  2017-12-11

2.  Genotyping of Francisella tularensis subsp. holarctica from Hares in Germany.

Authors:  Jörg Linde; Timo Homeier-Bachmann; Alexandra Dangel; Julia M Riehm; David Sundell; Caroline Öhrman; Mats Forsman; Herbert Tomaso
Journal:  Microorganisms       Date:  2020-12-05

3.  Genomic characterization of Francisella tularensis and other diverse Francisella species from complex samples.

Authors:  David M Wagner; Dawn N Birdsell; Ryelan F McDonough; Roxanne Nottingham; Karisma Kocos; Kimberly Celona; Yasemin Özsürekci; Caroline Öhrman; Linda Karlsson; Kerstin Myrtennäs; Andreas Sjödin; Anders Johansson; Paul S Keim; Mats Forsman; Jason W Sahl
Journal:  PLoS One       Date:  2022-10-12       Impact factor: 3.752

4.  The use of Matrix-assisted laser desorption ionization-time of flight mass spectrometry in the identification of Francisella tularensis.

Authors:  Onur Karatuna; Bekir Celebi; Simge Can; Isin Akyar; Selcuk Kilic
Journal:  Bosn J Basic Med Sci       Date:  2016-01-15       Impact factor: 3.363

5.  Water as Source of Francisella tularensis Infection in Humans, Turkey.

Authors:  Selcuk Kilic; Dawn N Birdsell; Alper Karagöz; Bekir Çelebi; Zekiye Bakkaloglu; Muzaffer Arikan; Jason W Sahl; Cedar Mitchell; Andrew Rivera; Sara Maltinsky; Paul Keim; Duran Üstek; Rıza Durmaz; David M Wagner
Journal:  Emerg Infect Dis       Date:  2015-12       Impact factor: 6.883

6.  Coinfections identified from metagenomic analysis of cervical lymph nodes from tularemia patients.

Authors:  D N Birdsell; Y Özsürekci; A Rawat; A E Aycan; C L Mitchell; J W Sahl; A Johansson; R E Colman; J M Schupp; M Ceyhan; P S Keim; D M Wagner
Journal:  BMC Infect Dis       Date:  2018-07-11       Impact factor: 3.090

7.  Molecular Survey of Tularemia and Plague in Small Mammals From Iran.

Authors:  Ehsan Mostafavi; Ahmad Ghasemi; Mahdi Rohani; Leila Molaeipoor; Saber Esmaeili; Zeinolabedin Mohammadi; Ahmad Mahmoudi; Mansour Aliabadian; Anders Johansson
Journal:  Front Cell Infect Microbiol       Date:  2018-07-10       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.